awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37112508-207F4474-8432-4677-85A8-F16FE30691C2
Q37112508-207F4474-8432-4677-85A8-F16FE30691C2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37112508-207F4474-8432-4677-85A8-F16FE30691C2
Advances in MRSA drug discovery: where are we and where do we need to be?
P2860
Q37112508-207F4474-8432-4677-85A8-F16FE30691C2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37112508-207F4474-8432-4677-85A8-F16FE30691C2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ed1bf48ced5c29943370bc3150d7f6034b17f9f9
P2860
Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients with complicated skin and skin structure infections.